Physician profile
Tori Raye Hazel
NPI 1578134979
$4,607.87
in general payments reported to CMS, 2019-2025
38 companies · $1,247 in 2025
The $1,247 reported for 2025 was more than what 89% of Gerontology (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $161).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $187 · 2022: $1,028 · 2023: $967 · 2024: $1,179 · 2025: $1,247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,985 · Education: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,985.48 |
| Education | $407.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $774.89 | 2022-2025 | Enhertu, Lynparza |
| Lilly USA, LLC | $387.63 | 2021-2025 | Verzenio, Jaypirca |
| Janssen Biotech, INC. | $351.47 | 2024-2025 | Rybrevant, Tecvayli, Carvykti |
| Genzyme Corporation | $313.99 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $252.70 | 2023-2025 | |
| Pharmacosmos Therapeutics INC. | $208.10 | 2022-2025 | Monoferric |
| Incyte Corporation | $189.72 | 2021-2025 | Jakafi, Zynyz, Monjuvi |
| Seagen INC. | $188.94 | 2021-2023 | Tukysa, Adcetris, Padcev |
| Sobi, INC | $186.95 | 2022-2025 | |
| Pfizer INC. | $184.28 | 2022-2025 | |
| Array Biopharma INC | $147.00 | 2021-2025 | Braftovi, Mektovi, Xalkori |
| E.R. Squibb & Sons, L.L.C. | $133.97 | 2023-2024 | Opdivo |
| Rigel Pharmaceuticals, INC. | $99.77 | 2022-2025 | Rezlidhia, Tavalisse, Gavreto |
| Amgen INC. | $96.43 | 2021-2023 | Lumakras |
| Sumitomo Pharma America, INC. | $94.36 | 2023-2024 | Orgovyx |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tori Hazel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.